Siew-leng Melinda Teng

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Thomas Powles, Joseph P. Eder, Gregg Fine et al. · Nature · 2014 · 2.4K citations

Medicine, Oncology, Pharmacology +12

Inhibition of PD-L1 by MPDL3280A and clinical activity in pts with metastatic urothelial bladder cancer (UBC).

Thomas Powles, Nicholas J. Vogelzang, Gregg Fine et al. · Journal of Clinical Oncology · 2014 · 96 citations

Medicine, Pharmacology, Pharmacotherapy +17

A phase Ia study of MPDL3280A (anti-PDL1): Updated response and survival data in urothelial bladder cancer (UBC).

Daniel P. Petrylak, Thomas Powles, Joaquim Bellmunt et al. · Journal of Clinical Oncology · 2015 · 63 citations

Medicine, Oncology, Urology +17

Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls

Fei Wang, Tianzi Jiang, Zhiguo Sun et al. · Journal of Psychiatry and Neuroscience · 2009 · 43 citations · Full text

Life Sciences, Genetics, Neuroscience +14

Clinical activity, safety, and biomarkers of MPDL3280A in metastatic urothelial bladder cancer: Additional analysis from phase IA study.

Joseph W. Kim, Joaquim Bellmunt, Thomas Powles et al. · Journal of Clinical Oncology · 2015 · 10 citations

Medicine, Oncology, Pharmacology +17